| II-101 Giulia Lestini Population pharmacokinetics and pharmacodynamics modeling of complement biomarkers and endpoints in C3 glomerulopathy (C3G) patients treated with iptacopan (FABHALTA®) Wednesday 15:20-16:50 |
| II-101 Giulia Lestini Population pharmacokinetics and pharmacodynamics modeling of complement biomarkers and endpoints in C3 glomerulopathy (C3G) patients treated with iptacopan (FABHALTA®) Wednesday 15:20-16:50 |